Where does Abb Vie Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abb Vie Inc. ranks #759 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abb Vie Inc. hold?

Abb Vie Inc. holds 604 US utility patents granted between 2015 and 2025, spanning 53 technology areas.

What is Abb Vie Inc.'s Innovation Score?

Abb Vie Inc. has an Innovation Score of 63.2 out of 100 (top 2% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Abb Vie Inc.'s patent grant rate increasing or decreasing?

Abb Vie Inc.'s recent grant velocity is -73% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Abb Vie Inc.'s patents?

Abb Vie Inc.'s patents average 17.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abb Vie Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Abb Vie Inc.

Q: What technology areas does Abb Vie Inc. focus on?

Abb Vie Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 391 patents. Grants appear in 53 CPC subclasses total.

USPTO PatentsView assignee record - 604 granted patents across 53 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abb ranks #759 of 49,997 tracked US assignees by granted-patent volume, with 604 patents across 53 technology areas.

#759
of 49,997 US assignees by volume: Top 2%
by Innovation Score (63.2/100): 17.7
avg claims per patent: -73%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R759 · US Corporation #759 · 604 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 604 grants
TOP-DECILE #759/49,997
PHOTO-FINISH SAS Institute
CPC-WIDE A61P · 53 areas
INNOV-STRONG 63.2/100
CLAIMS-RICH 17.7 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -73% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: SAS Institute, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Nederlandse… · near

63
Palo Alto Research… · near

63
Abb Vie · this assignee

63
Siemens Healthcare… · near

63
Fresenius Medical… · near

63
3D Lighting… · lowest

7

What this shows Abb's Innovation Score is 63.2/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Abb's grant cadence moved

Between 2020–2024, Abb Vie Inc. received 128 grants versus 468 in 2015–2019 (-73% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 150 grants and bottomed in 2021 at 18. Lead class A61P accounts for 64.7% of the portfolio across 53 subclasses. Volume neighbours: Essilor International (#755) and Ethicon Endo-Surgery, Inc. (#763).

Abb's three-year grant acceleration

From 2019–2021 to 2022–2024, Abb Vie Inc. moved from 93 to 76 grants (0.82x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,782. See the growth leaderboard.

Essilor Internati…

606
Sysmex

606
Carl Zeiss Micros…

605
Parker-hannifin

605
SAS Institute

604
Abb Vie ◀

604
DIC

602
Maxlinear

602
Ethicon Endo-surg…

601

What this shows Abb holds 604 patents at rank #759, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abb

By rank, the assignees closest to #759 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Abb's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abb, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (63 here).

Siemens Healthcare Diagnostics Inc. 63 Fresenius Medical Care Deutschland GmbH 63 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO 63 Palo Alto Research Center Incorporated 63

Similar claim depth

Nearest assignees by average claims per patent (17.7 here).

The Research Foundation for The State University of New York 17.7 avg Johns Manville 17.7 avg Infineon Technologies Americas Corp. 17.7 avg Zephyros, Inc. 17.7 avg

Abb's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abb Vie Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	150	24.8%
2016	120	19.9%
2017	82	13.6%
2018	75	12.4%
2019	41	6.8%
2020	34	5.6%
2021	18	3.0%
2022	21	3.5%
2023	30	5.0%
2024	25	4.1%
2025partial year	8	1.3%

Which technologies does Abb Vie Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 391

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 333

C07D - Heterocyclic Compounds 284

C07K - Peptides 162

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 64

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 53

C07C - Acyclic OR Carbocyclic Compounds 51

Y02A - Technologies FOR Adaptation TO Climate Change 39

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 36

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 35

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 30

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 18

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 13

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 12

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 12

Top 15 of 53 technology areas

Where it ranks

Overall rank by patents

#759

of 49,997 tracked assignees

Innovation Score

63.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Abb Vie Inc.'s patent record in context - here's where to go next.

Abb Vie Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 64.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #759 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abb Vie Inc. against Essilor International, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 63.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.